Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein.

Transmission studies have suggested that an optimal human immunodeficiency virus type 1 (HIV-1) vaccine should induce both neutralizing antibodies and cytolytic T cells to eliminate free virus and infected cells. A phase I trial in healthy HIV-1-seronegative persons was conducted with a combination...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Cooney, E L, McElrath, M J, Corey, L, Hu, S L, Collier, A C, Arditti, D, Hoffman, M, Coombs, R W, Smith, G E, Greenberg, P D
Format: Artigo
Jezik:Inglês
Izdano: 1993
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC45984/
https://ncbi.nlm.nih.gov/pubmed/8446603
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items